30 results
Thumbnail

D2.521 - Reshaping Allergy Assessment Pathways In The United Kingdom: Modeling System-Level Gains Through Discrete Event Simulation

Thumbnail

D2.522 - An Observational Study of techniques of Intanasal Spray in Allergic Rhinitis

Thumbnail

D2.524 - How much does wheat oral immunotherapy improve quality of life?

Thumbnail

D2.530 - Digital patient-reported data uncover key clinical features of mastocytosis: insights from the MASTHAVE App

Thumbnail

D2.532 - Does Bathing Frequency Matter in Pediatric Atopic Dermatitis? Insights from Real-Life Practice

Thumbnail

D2.533 - Characterizing Elderly Asthma Hospitalizations: Insights into Treatment Gaps and Outcomes; A Real‑World Study Using the MIMIC‑IV Dataset

Thumbnail

D2.523 - Dyadic parenting stress and marital communication among parents of young children with food allergies

Thumbnail

D2.527 - Lessening the food allergy burden through education: A Canadian focus

Thumbnail

D2.528 - Corticophobia Among Caregivers of Children with Atopic Diseases: Causes and Outcomes

Thumbnail

D2.529 - Asymptomatıc QT Prolongatıon Developıng After Antıhıstamıne Use

Thumbnail

D2.531 - Expert Panel Discussion on a New Oral On-Demand Treatment in Hereditary Angioedema

Thumbnail

D2.536 - Seasonal Influenza Vaccination: Uptake Rate, Profile, and Motivating Factors Among Healthcare Workers

Thumbnail

D2.537 - Advances in Drug Allergy & Penicillin Testing Phase 2 (ADAPT-2): an AI-powered drug allergy educational initiative spanning across 4 localities

Thumbnail

D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study

Thumbnail

D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study

Thumbnail

D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial

Thumbnail

D3.439 - Donidalorsen For The Treatment Of Hereditary Angioedema: 1-Year Results From The OASISplus Open-Label Extension Cohort